학술논문

Misfolded SOD1 is not a primary component of sporadic ALS
Document Type
article
Source
Acta Neuropathologica. 134(1)
Subject
Biomedical and Clinical Sciences
Neurosciences
ALS
Rare Diseases
Brain Disorders
Neurodegenerative
Aetiology
2.1 Biological and endogenous factors
Neurological
Adult
Aged
Aged
80 and over
Amyotrophic Lateral Sclerosis
Animals
Cerebral Cortex
Disease Models
Animal
Female
Humans
Immunohistochemistry
Immunoprecipitation
Male
Mice
Transgenic
Middle Aged
Protein Folding
Spinal Cord
Superoxide Dismutase-1
Young Adult
Amyotrophic lateral sclerosis
Superoxide dismutase
Misfolding
Sporadic
Neurodegeneration
Human patients
Neuropathology
Clinical Sciences
Neurology & Neurosurgery
Language
Abstract
A common feature of inherited and sporadic ALS is accumulation of abnormal proteinaceous inclusions in motor neurons and glia. SOD1 is the major protein component accumulating in patients with SOD1 mutations, as well as in mutant SOD1 mouse models. ALS-linked mutations of SOD1 have been shown to increase its propensity to misfold and/or aggregate. Antibodies specific for monomeric or misfolded SOD1 have detected misfolded SOD1 accumulating predominantly in spinal cord motor neurons of ALS patients with SOD1 mutations. We now use seven different conformationally sensitive antibodies to misfolded human SOD1 (including novel high affinity antibodies currently in pre-clinical development) coupled with immunohistochemistry, immunofluorescence and immunoprecipitation to test for the presence of misfolded SOD1 in high quality human autopsy samples. Whereas misfolded SOD1 is readily detectable in samples from patients with SOD1 mutations, it is below detection limits for all of our measures in spinal cord and cortex tissues from patients with sporadic or non-SOD1 inherited ALS. The absence of evidence for accumulated misfolded SOD1 supports a conclusion that SOD1 misfolding is not a primary component of sporadic ALS.